Maze Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular, and related metabolic, or CVRM diseases. Its pipeline includes the Compass platform, which allows it to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process to refer a variant functionalization. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman on August 29, 2017 and is headquartered in San Francisco, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
141
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Maze Therapeutics Inc. market cap is $1.8B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Maze Therapeutics Inc. 52 week high is $53.65 as of November 18, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Maze Therapeutics Inc. 52 week low is $21.95 as of November 18, 2026.
Maze Therapeutics Inc. stock price today is $31.20.
Maze Therapeutics Inc. stock price yesterday was $32.87.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Maze Therapeutics Inc.'s P/E ratio is -12.19.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Maze Therapeutics Inc. P/B ratio is 4.3297.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Maze Therapeutics Inc. 50-day moving average is $28.97.